Persistent URL of this record https://hdl.handle.net/1887/3564262
In Collections
This item can be found in the following collections:
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT
- All authors
- Vincent, L.; Gras, L.; Ceballos, P.; Finke, J.; Passweg, J.; Harel, S.; Rosinol, L.; Minnema, M.; Teipel, R.; Doesum, J. van; Hanel, M.; Lenain, P.; Botella-Garcia, C.; Koenecke, C.; Ducastelle, S.; Sanz, J.; Schroyens, W.; Zuckerman, T.; Monaco, F.; Koster, L.; Wreede, L. de; Hayden, P.J.; Schonland, S.; Yakoub-Agha, I.; Beksac, M.
- Date
- 2022-01-10
- Volume
- 57
- Issue
- 3
- Pages
- 499 - 501